The article discusses the insights of Dr. Linamara Rizzo Battistella, a prominent figure in rehabilitation medicine in Brazil, regarding the clinical trials of polylaminin, a substance showing promise for treating acute spinal cord injuries. Dr. Battistella critiques the current approach that places rehabilitation as a secondary concern, advocating instead for a comprehensive daily therapeutic regimen for patients. She stresses that miracles in medicine come from well-executed science, not overlooked aspects of care.

Dr. Battistella, who has been involved in the care of spinal cord injury patients for over four decades, highlights the inadequacy of providing rehabilitation only three times a week post-treatment with polylaminin. According to her, effective rehabilitation should be intensive and frequent, accommodating the unique needs of patients and maximizing the substance's potential benefits. The implication of her stance is that without proper rehabilitation, the efficacy of polylaminin may not be fully realized, potentially hindering advancements in treatment.

Furthermore, the article raises concerns about the overall methodology of the clinical trials and the understanding of rehabilitation among those conducting the studies. By prioritizing rehabilitation, the researchers could enhance patient outcomes and provide a more holistic approach to treating spinal cord injuries. Dr. Battistella's comments aim to advocate for a paradigm shift in how rehabilitation is integrated into therapeutic protocols for acute spinal conditions.